Physician profile
Sumit N Ringwala
NPI 1316089154
$7,696.31
in general payments reported to CMS, 2019-2025
17 companies · $4,291 in 2025
The $4,291 reported for 2025 was more than what 81% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2020: $83.32 · 2022: $380 · 2023: $2,070 · 2024: $755 · 2025: $4,291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,650 · Travel and Lodging: $1,788 · Food and Beverage: $1,078 · Honoraria: $500 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,650.00 |
| Travel and Lodging | $1,788.39 |
| Food and Beverage | $1,077.75 |
| Honoraria | $500.00 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,239.92 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Artix Mt |
| Abiomed | $1,338.07 | 2023 | Impella |
| Inari Medical, INC. | $1,202.41 | 2023-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $971.83 | 2025 | General - Vascular Access, Avvigo Guidance System, Watchman Flx |
| W. L. Gore & Associates, INC. | $233.98 | 2022-2025 | Gore Tag Thoracic Branch Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo |
| Penumbra, INC. | $194.16 | 2022 | |
| Janssen Pharmaceuticals, INC | $135.18 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $99.99 | 2023 | Opsumit, Uptravi |
| Surmodics, INC. | $92.35 | 2023-2025 | Pounce Venous Thrombectomy System, Pounce Thrombectomy, Pounce Thrombectomy System |
| Medtronic, INC. | $47.39 | 2024 | Onyx Frontier |
| Novartis Pharmaceuticals Corporation | $36.35 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $22.08 | 2025 | Tezspire |
| Bard Peripheral Vascular, INC. | $21.79 | 2023 | Rotarexs 6 F X 135 Cm |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.73 | 2024 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $15.26 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.04 | 2020 | |
| Cardiovascular Systems INC. | $13.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sumit Ringwala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.